Physician profile
David B Mallory
NPI 1093725368
$1,087.44
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $722 · 2020: $217 · 2021: $105 · 2022: $42.40.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $279.52 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $173.44 | 2019-2022 | |
| Alcon Vision LLC | $170.42 | 2019 | |
| Shire North American Group INC | $166.09 | 2019 | |
| Biotissue Holdings INC. | $113.83 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $109.91 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $50.96 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $12.05 | 2022 | |
| Omeros Corporation | $11.22 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mallory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.